We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
908 Devices
MASS
$408M
| $1M | ﹤0.01% |
190,635
-249,004
| -57% | -$1.74M |
|
|
OTGAW
1902
CALL
OTG Acquisition Corp I Warrants
OTGAW
| $1M | ﹤0.01% |
+100,000
| New | +$33.3K |
|
|
MESHU
1903
Meshflow Acquisition Corp Units
MESHU
$304M
| $1M | ﹤0.01% |
+100,000
| New | +$1M |
|
1904
CALL
Centene
CNC
$33.1B
| $1,000K | ﹤0.01% |
24,300
-17,400
| -42% | -$651K |
|
|
ADACU
1905
American Drive Acquisition Co Units
ADACU
| $999K | ﹤0.01% |
+100,000
| New | +$997K |
|
1906
Tenaya Therapeutics
TNYA
$175M
| $998K | ﹤0.01% |
1,406,035
+1,388,750
| +8,034% | +$1.89M |
|
|
LPCVU
1907
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
| $998K | ﹤0.01% |
+100,000
| New | +$999K |
|
1908
Weibo
WB
$1.9B
| $996K | ﹤0.01% |
97,433
+75,549
| +345% | +$811K |
|
|
PLG
1909
Platinum Group Metals
PLG
$198M
| $994K | ﹤0.01% |
421,006
-450,827
| -52% | -$1.09M |
|
1910
Unilever
UL
$133B
| $993K | ﹤0.01% |
15,185
-63,651
| -81% | -$4.28M |
|
|
PVLA
1911
Palvella Therapeutics
PVLA
$2.26B
| $993K | ﹤0.01% |
+9,484
| New | +$809K |
|
|
API
1912
Agora
API
$386M
| $992K | ﹤0.01% |
243,825
-302,941
| -55% | -$1.11M |
|
1913
PUT
iShares US Home Construction ETF
ITB
$2.35B
| $992K | ﹤0.01% |
+10,300
| New | +$1.04M |
|
1914
Sutro Biopharma
STRO
$325M
| $991K | ﹤0.01% |
85,615
+73,771
| +623% | +$700K |
|
1915
Forte Biosciences
FBRX
$1.58B
| $990K | ﹤0.01% |
36,297
+17,132
| +89% | +$300K |
|
|
RNGTW
1916
CALL
Range Capital Acquisition Corp II Warrants
RNGTW
$3.9M
| $989K | ﹤0.01% |
+99,141
| New | +$40.4K |
|
|
CBLL
1917
CeriBell Inc
CBLL
$837M
| $988K | ﹤0.01% |
45,061
-1,715
| -4% | -$26.6K |
|
1918
CALL
Spotify
SPOT
$101B
| $987K | ﹤0.01% |
1,700
+1,500
| +750% | +$938K |
|
1919
Quanterix
QTRX
$123M
| $987K | ﹤0.01% |
155,169
-453,539
| -75% | -$2.82M |
|
1920
Wabash National
WNC
$496M
| $986K | ﹤0.01% |
113,948
+99,599
| +694% | +$869K |
|
1921
Fennec Pharmaceuticals
FENC
$422M
| $983K | ﹤0.01% |
+127,693
| New | +$1.05M |
|
1922
Evolent Health
EVH
$495M
| $982K | ﹤0.01% |
245,554
-409,193
| -62% | -$2.27M |
|
1923
Sportsman's Warehouse
SPWH
$46M
| $976K | ﹤0.01% |
668,221
-406,327
| -38% | -$884K |
|
1924
Texas Roadhouse
TXRH
$13.9B
| $975K | ﹤0.01% |
5,876
-3,037
| -34% | -$514K |
|
|
VBNK
1925
VersaBank
VBNK
$617M
| $973K | ﹤0.01% |
64,939
-90,088
| -58% | -$1.14M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.